Company Overview of BioTissue Technologies GmbH
BioTissue Technologies GmbH provides ortho-biological solutions for cartilage defects for patients and health professionals. It offers BioSeed, a three dimensional autologous chondrocyte graft to treat articular cartilage defects in the knee; and chondrotissue, a one-step, CE marked, and cell-free implant used to treat articular cartilage defects in the knee, ankle, or hip. BioTissue Technologies GmbH was founded in 1997 and is based in Freiburg, Germany.
Founded in 1997
49 761 7676 580
49 761 7676 430
Key Executives for BioTissue Technologies GmbH
Similar Private Companies By Industry
|Capsulution Pharma AG||Europe|
|MALTAgen Forschung GmbH||Europe|
|TransTissue Technologies GmbH||Europe|
|ARTES Biotechnology GmbH||Europe|
|SIFIN Institut für Immunpräparate und Nährmedien GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact BioTissue Technologies GmbH, please visit www.biotissue.de. Company data is provided by Capital IQ. Please use this form to report any data issues.